ABT:NYE-Abbott Laboratories (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 129.89

Change

-1.09 (-0.83)%

Market Cap

USD 220.05B

Volume

6.05M

Analyst Target

USD 115.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
MDT Medtronic PLC

-0.80 (-0.97%)

USD 106.32B
ZBH Zimmer Biomet Holdings Inc

-1.75 (-1.79%)

USD 22.25B
STE STERIS plc

-3.45 (-1.55%)

USD 22.15B
SNN Smith & Nephew SNATS Inc

-0.23 (-0.89%)

USD 11.31B
PEN Penumbra Inc

-6.71 (-2.42%)

USD 10.73B
GMED Globus Medical

-1.62 (-2.28%)

USD 9.77B
BIO Bio-Rad Laboratories Inc

-1.30 (-0.55%)

USD 6.94B
BIO-B Bio-Rad Laboratories Inc

+9.12 (+4.05%)

USD 6.39B
GKOS Glaukos Corp

-1.96 (-2.17%)

USD 5.15B
INSP Inspire Medical Systems Inc

-5.51 (-3.67%)

USD 4.39B

ETFs Containing ABT

UMDV:SW iShares US Medical Device.. 16.05 % 0.00 %

N/A

N/A
EDOC:AU 7.78 % 0.00 %

N/A

N/A
LIFE:CA Evolve Global Healthcare .. 5.48 % 0.69 %

-0.21 (0.00%)

CAD 0.22B
GDOC Goldman Sachs ETF Trust 5.40 % 0.00 %

-0.47 (0.00%)

USD 0.02B
FHI:CA CI Health Care Giants Cov.. 5.25 % 0.75 %

-0.18 (0.00%)

CAD 0.10B
HART IQ Healthy Hearts ETF 5.09 % 0.00 %

-0.50 (0.00%)

USD 9.15M
LIFE-U:CA Evolve Global Healthcare .. 5.05 % 0.00 %

N/A

N/A
CWS AdvisorShares Focused Equ.. 4.72 % 0.68 %

-1.71 (0.00%)

USD 0.17B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.68 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.61 % 0.00 %

N/A

N/A
XLV Health Care Select Sector.. 4.53 % 0.13 %

-2.92 (0.00%)

USD 35.08B
QLTY The 2023 ETF Series Trust.. 4.51 % 0.00 %

-0.65 (0.00%)

USD 1.58B
SXLV:SW SPDR S&P U.S. Health Care.. 4.39 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.35 % 0.00 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 3.96 % 0.08 %

-1.32 (0.00%)

USD 2.50B
IUAE:CA Invesco S&P US Dividend A.. 3.60 % 0.00 %

-0.49 (0.00%)

CAD 1.21M
DRUG:AU BetaShares Global Healthc.. 3.59 % 0.00 %

N/A

USD 0.17B
MIVG:CA Mackenzie Ivy Global Equi.. 3.55 % 0.89 %

-0.98 (0.00%)

CAD 0.02B
WELG:XETRA Amundi S&P Global Health .. 3.46 % 0.00 %

N/A

N/A
WELS:XETRA Amundi S&P Global Health .. 3.46 % 0.00 %

N/A

N/A
XUHC:SW 3.38 % 0.00 %

N/A

N/A
FOHW:XETRA Franklin Future of Health.. 3.37 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.36 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.36 % 0.00 %

N/A

N/A
BRIF NEOS ETF Trust 3.33 % 0.00 %

-0.62 (0.00%)

N/A
SPLV:SW iShares Edge S&P 500 Mini.. 3.28 % 0.00 %

N/A

USD 1.23B
SPMV Invesco S&P 500 Minimum V.. 3.12 % 0.00 %

-0.92 (0.00%)

USD 5.63M
XWHS:LSE Xtrackers MSCI World Heal.. 3.04 % 0.00 %

N/A

USD 2.72B
WHEA:SW SPDR MSCI World Health Ca.. 3.03 % 0.00 %

N/A

N/A
HEAL:CA 2.82 % 0.00 %

N/A

N/A
VALQ American Century STOXX U... 2.79 % 0.29 %

-0.84 (0.00%)

USD 0.22B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.36 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.36 % 0.00 %

N/A

N/A
AIAA:XETRA Ishares Iii Plc - Ishares.. 2.26 % 0.00 %

N/A

N/A
2B78:XETRA iShares Healthcare Innova.. 2.13 % 0.00 %

N/A

USD 1.05B
XDU:CA iShares Core MSCI US Qual.. 2.12 % 0.16 %

-0.42 (0.00%)

CAD 0.23B
CGCV Capital Group Conservativ.. 2.06 % 0.00 %

-0.45 (0.00%)

USD 0.25B
HEAL:SW iShares Healthcare Innova.. 1.98 % 0.00 %

N/A

USD 1.05B
XHE SPDR® S&P Health Care Eq.. 1.90 % 0.35 %

-1.08 (0.00%)

USD 0.16B
ZUH:CA BMO Equal Weight US Healt.. 1.85 % 0.39 %

-1.38 (0.00%)

CAD 0.21B
MFUT MFUT 1.77 % 0.00 %

-0.05 (0.00%)

USD 0.02B
HYLG 1.58 % 0.00 %

N/A

N/A
IUSD:XETRA iShares MSCI World Islami.. 1.49 % 0.00 %

N/A

N/A
ISWD:SW iShares MSCI World Islami.. 1.43 % 0.00 %

N/A

USD 0.65B
DFUV Dimensional US Marketwide.. 1.30 % 0.00 %

-0.70 (0.00%)

USD 10.42B
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.44 % 0.00 %

N/A

USD 2.73B
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

N/A

USD 0.21B
SP2Q:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

N/A

USD 1.55B
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

N/A

USD 12.74B
XDEW:SW Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

N/A

USD 11.30B
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

-5.42 (0.00%)

USD 0.12B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

-1.18 (0.00%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

-0.50 (0.00%)

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

-0.64 (0.00%)

USD 5.35B
RWDC 0.00 % 0.00 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

-0.89 (0.00%)

CAD 0.01B
GDNA 0.00 % 0.00 %

N/A

N/A
HHL-U:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

-0.18 (0.00%)

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.53 (+0.00%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.53 (+0.00%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-1.72 (0.00%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-5.38 (0.00%)

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-1.29 (0.00%)

CAD 0.56B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
ISDU:LSE iShares MSCI USA Islamic .. 0.00 % 0.00 %

N/A

USD 0.23B
ISUS:LSE iShares MSCI USA Islamic .. 0.00 % 0.00 %

N/A

USD 0.24B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

N/A

USD 2.40B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
XGDD:LSE Xtrackers - Stoxx Global .. 0.00 % 0.00 %

N/A

N/A
XGSD:LSE Xtrackers Stoxx Global Se.. 0.00 % 0.00 %

N/A

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.65B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.65B
DXSB:F 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
TSWE:F VanEck Sustainable World .. 0.00 % 0.00 %

N/A

USD 0.72B
XDEW:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 13.13B
XDND:F Xtrackers MSCI North Amer.. 0.00 % 0.00 %

N/A

USD 0.11B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 2.60B
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

USD 0.40B
DXSB:XETRA Xtrackers - Stoxx Global .. 0.00 % 0.00 %

N/A

USD 0.68B
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

N/A
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

N/A

USD 1.47B
ANEW ProShares MSCI Transforma.. 0.00 % 0.00 %

-0.73 (0.00%)

USD 8.34M
BMED BlackRock Future Health E.. 0.00 % 0.00 %

-0.23 (0.00%)

USD 2.67M
HHL-B:CA Harvest Healthcare Leader.. 0.00 % 0.00 %

-0.16 (0.00%)

N/A
FUD-A:CA 0.00 % 0.00 %

N/A

N/A
XDU-U:CA iShares Core MSCI US Qual.. 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

-0.21 (0.00%)

CAD 0.08B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.84% 92% A 95% A
Dividend Return 1.04% 75% C 48% F
Total Return 15.88% 92% A 95% A
Trailing 12 Months  
Capital Gain 21.31% 77% C+ 90% A-
Dividend Return 2.13% 71% C- 40% F
Total Return 23.44% 77% C+ 90% A-
Trailing 5 Years  
Capital Gain 36.04% 65% D 52% F
Dividend Return 10.28% 88% B+ 23% F
Total Return 46.32% 65% D 45% F
Average Annual (5 Year Horizon)  
Capital Gain 0.74% 53% F 38% F
Dividend Return 2.18% 53% F 34% F
Total Return 1.45% 75% C 35% F
Risk Return Profile  
Volatility (Standard Deviation) 17.20% 97% N/A 59% D-
Risk Adjusted Return 12.68% 59% D- 31% F
Market Capitalization 220.05B 100% F 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.